<p>Cardlytics（纳斯达克股票代码：CDLX - 获取免费报告）在周三的研究报告中被 Craig Hallum 的股票分析师从 “持有” 评级上调至 “强力买入” 评级，Zacks.com 报道。</p>
<p>其他一些分析师最近也对 CDLX 发布了报告。Lake Street Capital 将 Cardlytics 的评级从 “买入” 下调至 “持有”，并将其股票目标价从 18.00 美元下调至 5.00 美元，报告日期为 8 月 8 日，星期四。Evercore ISI 在 10 月 11 日，星期五开始对 Cardlytics 进行覆盖，给予 “持平” 评级和 4.00 美元的目标价。Northland Securities 将 Cardlytics 的评级从 “跑赢大盘” 下调至 “市场表现”，并将其股票目标价从 7.00 美元下调至 5.00 美元，报告日期为 8 月 16 日，星期五。美国银行将 Cardlytics 的评级从 “中性” 下调至 “表现不佳”，并将其股票目标价从 4.00 美元下调至 3.50 美元，报告日期为 8 月 15 日，星期四。最后，Needham &amp; Company LLC 在周四的报告中重申了对 Cardlytics 股票的 “持有” 评级。一位投资分析师给予该股票 “卖出” 评级，五位分析师给予 “持有” 评级，一位分析师给予 “强力买入” 评级。根据 MarketBeat 的数据，该公司的平均评级为 “持有”，共识目标价为 6.92 美元。</p>
<p><strong>查看我们对 Cardlytics 的最新分析</strong></p>
<h2>Cardlytics 股票下跌 21.9%</h2>
<p>CDLX 的股票在周三以 4.07 美元开盘。该公司的 50 日移动平均线为 3.68 美元，200 日移动平均线为 6.76 美元。公司市值为 2.0285 亿美元，市盈率为-1.06，贝塔值为 1.61。Cardlytics 的 12 个月低点为 2.89 美元，12 个月高点为 20.52 美元。该公司的流动比率为 1.77，速动比率为 1.77，债务与股本比率为 1.01。</p>
<p>Cardlytics（纳斯达克股票代码：CDLX - 获取免费报告）最近在 8 月 7 日，星期三发布了季度财报。公司报告每股收益（EPS）为-0.09 美元，超出分析师的共识预期（-0.21 美元）0.12 美元。Cardlytics 的股本回报率为-17.96%，净利润率为-50.21%。该公司季度收入为 6964 万美元，而共识预期为 7539 万美元。在去年同期，该公司每股收益为-0.57 美元。与去年同期相比，该公司的收入下降了 9.2%。研究分析师预计 Cardlytics 在当前财年将发布-1.72 美元的每股收益。</p>
<h2>Cardlytics 内部活动</h2>
<p>在其他 Cardlytics 的新闻中，董事 Scott A. Hill 在 8 月 12 日，星期一以每股平均价格 3.58 美元购买了 40,000 股公司的股票，总交易额为 143,200.00 美元。收购后，该董事现在直接持有 40,000 股公司股票，价值 143,200 美元。该交易已在向证券交易委员会提交的文件中披露，文件可通过此链接获取。在其他新闻中，首席执行官 Amit Gupta 在 10 月 24 日，星期四出售了 22,607 股股票，出售价格为每股 3.85 美元，总交易额为 87,036.95 美元。交易后，首席执行官现在持有 178,519 股公司股票，价值约 687,298.15 美元。这代表其持股比例下降了 0.00%。该交易已在向证券交易委员会提交的文件中披露，文件可通过此链接获取。此外，董事 Scott A. Hill 在 8 月 12 日，星期一以每股平均价格 3.58 美元购买了 40,000 股公司的股票，总交易额为 143,200.00 美元。交易后，该董事现在直接持有 40,000 股公司股票，价值约 143,200 美元。该购买的披露信息可在此处找到。内部人士在上个季度共出售了价值 151,612 美元的 43,573 股公司股票。公司内部人士持有 4.40% 的股份。</p>
<h2>对 Cardlytics 的对冲基金看法</h2>
<p>一些对冲基金和其他机构投资者最近对 CDLX 的持仓进行了调整。Canton Hathaway LLC 在第二季度将其在 Cardlytics 的持仓增加了 95.7%。Canton Hathaway LLC 现在持有 4,500 股公司股票，价值 37,000 美元，此前在上个季度又购买了 2,200 股。SG Americas Securities LLC 在第三季度购买了 Cardlytics 的新头寸，价值 45,000 美元。Creative Planning 在第三季度将其在 Cardlytics 的持仓增加了 35.4%。Creative Planning 现在持有 29,537 股公司股票，价值 95,000 美元，此前在上个季度又购买了 7,721 股。XTX Topco Ltd 在第二季度购买了 Cardlytics 的新头寸，价值 107,000 美元。最后，Quest Partners LLC 在第二季度将其在 Cardlytics 的持仓增加了 160.4%。Quest Partners LLC 现在持有 17,956 股公司股票，价值 147,000 美元，此前在上个季度又购买了 11,061 股。机构投资者持有公司 68.10% 的股份。</p>
<h2>Cardlytics 公司简介</h2>
<p>（获取免费报告）</p>
<p>Cardlytics, Inc 在美国和英国运营一个广告平台。它提供 Cardlytics 平台，这是一个专有的本地银行广告渠道，使营销人员能够通过其金融机构合作伙伴的网络通过在线、移动应用程序、电子邮件和各种实时通知等数字渠道接触客户；以及 Bridg 平台，这是一个客户数据平台，利用销售点数据，使营销人员能够进行分析和针对性忠诚营销，并衡量其营销的影响。</p>
<h2>推荐故事</h2>
<ul>
<li>我们更看好的五只股票，而不是 Cardlytics</li>
<li>每月分红股票的利弊</li>
<li>吉利德股票飙升：是什么推动了这一势头？</li>
<li>分红支付比率计算器</li>
<li>突破警报：高通刚刚按下了反弹按钮</li>
<li>ESG 股票，投资者应该知道什么</li>
<li>Mercado Libre 股票降价：现在是购买的时机吗？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0RMWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0RMWA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<p>→ 前白宫顾问预测拜登退出竞选，做出惊人新预测（来自 Paradigm Press）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDM5Mg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDM5Mg"/></p>
<h2>你现在应该投资 1,000 美元在 Cardlytics 吗？</h2>
<p>在考虑 Cardlytics 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Cardlytics 并不在名单上。</p>
<p>虽然 Cardlytics 目前在分析师中被评为 “减持”，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

CDLX

<p>Craig Hallum 在最近的一份报告中将 Cardlytics (NASDAQ:CDLX) 的评级从 “持有” 上调至 “强力买入”。其他分析师的看法则不一，Lake Street Capital 将该股票下调至 “持有”，而美国银行则下调至 “表现不佳”。Cardlytics 的股票开盘价为 0.07 美元，下跌 21.9%，市值为 8500 万美元。该公司报告的季度每股收益为 -0.09 美元，超出预期，但收入同比下降 9.2%。内部交易活动包括一名董事购买了 40,000 股，首席执行官出售了 22,607 股</p>

<p>Cardlytics (NASDAQ:CDLX - Get Free Report) was upgraded by stock analysts at Craig Hallum from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note issued on Wednesday,Zacks.com reports.</p>
<div class="lb-trans"><p>Cardlytics（纳斯达克股票代码：CDLX - 获取免费报告）在周三的研究报告中被 Craig Hallum 的股票分析师从 “持有” 评级上调至 “强力买入” 评级，Zacks.com 报道。</p>
</div><p>A number of other analysts also recently issued reports on CDLX. Lake Street Capital downgraded Cardlytics from a &#34;buy&#34; rating to a &#34;hold&#34; rating and reduced their price objective for the stock from $18.00 to $5.00 in a research note on Thursday, August 8th. Evercore ISI began coverage on Cardlytics in a report on Friday, October 11th. They issued an &#34;in-line&#34; rating and a $4.00 target price for the company. Northland Securities cut Cardlytics from an &#34;outperform&#34; rating to a &#34;market perform&#34; rating and dropped their target price for the stock from $7.00 to $5.00 in a report on Friday, August 16th. Bank of America cut Cardlytics from a &#34;neutral&#34; rating to an &#34;underperform&#34; rating and dropped their target price for the stock from $4.00 to $3.50 in a report on Thursday, August 15th. Finally, Needham &amp; Company LLC reiterated a &#34;hold&#34; rating on shares of Cardlytics in a report on Thursday. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of &#34;Hold&#34; and a consensus price target of $6.92.</p>
<div class="lb-trans"><p>其他一些分析师最近也对 CDLX 发布了报告。Lake Street Capital 将 Cardlytics 的评级从 “买入” 下调至 “持有”，并将其股票目标价从 18.00 美元下调至 5.00 美元，报告日期为 8 月 8 日，星期四。Evercore ISI 在 10 月 11 日，星期五开始对 Cardlytics 进行覆盖，给予 “持平” 评级和 4.00 美元的目标价。Northland Securities 将 Cardlytics 的评级从 “跑赢大盘” 下调至 “市场表现”，并将其股票目标价从 7.00 美元下调至 5.00 美元，报告日期为 8 月 16 日，星期五。美国银行将 Cardlytics 的评级从 “中性” 下调至 “表现不佳”，并将其股票目标价从 4.00 美元下调至 3.50 美元，报告日期为 8 月 15 日，星期四。最后，Needham &amp; Company LLC 在周四的报告中重申了对 Cardlytics 股票的 “持有” 评级。一位投资分析师给予该股票 “卖出” 评级，五位分析师给予 “持有” 评级，一位分析师给予 “强力买入” 评级。根据 MarketBeat 的数据，该公司的平均评级为 “持有”，共识目标价为 6.92 美元。</p>
</div><p><strong>Check Out Our Latest Analysis on Cardlytics</strong></p>
<div class="lb-trans"><p><strong>查看我们对 Cardlytics 的最新分析</strong></p>
</div><h2>Cardlytics Stock Down 21.9 %</h2>
<div class="lb-trans"><h2>Cardlytics 股票下跌 21.9%</h2>
</div><p>Shares of CDLX opened at $4.07 on Wednesday. The business's 50 day moving average is $3.68 and its 200 day moving average is $6.76. The company has a market capitalization of $202.85 million, a PE ratio of -1.06 and a beta of 1.61. Cardlytics has a 12-month low of $2.89 and a 12-month high of $20.52. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 1.01.</p>
<div class="lb-trans"><p>CDLX 的股票在周三以 4.07 美元开盘。该公司的 50 日移动平均线为 3.68 美元，200 日移动平均线为 6.76 美元。公司市值为 2.0285 亿美元，市盈率为-1.06，贝塔值为 1.61。Cardlytics 的 12 个月低点为 2.89 美元，12 个月高点为 20.52 美元。该公司的流动比率为 1.77，速动比率为 1.77，债务与股本比率为 1.01。</p>
</div><p>Cardlytics (NASDAQ:CDLX - Get Free Report) last released its quarterly earnings data on Wednesday, August 7th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.21) by $0.12. Cardlytics had a negative return on equity of 17.96% and a negative net margin of 50.21%. The business had revenue of $69.64 million for the quarter, compared to the consensus estimate of $75.39 million. During the same quarter in the previous year, the company posted ($0.57) EPS. The company's revenue was down 9.2% compared to the same quarter last year. Research analysts expect that Cardlytics will post -1.72 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Cardlytics（纳斯达克股票代码：CDLX - 获取免费报告）最近在 8 月 7 日，星期三发布了季度财报。公司报告每股收益（EPS）为-0.09 美元，超出分析师的共识预期（-0.21 美元）0.12 美元。Cardlytics 的股本回报率为-17.96%，净利润率为-50.21%。该公司季度收入为 6964 万美元，而共识预期为 7539 万美元。在去年同期，该公司每股收益为-0.57 美元。与去年同期相比，该公司的收入下降了 9.2%。研究分析师预计 Cardlytics 在当前财年将发布-1.72 美元的每股收益。</p>
</div><h2>Insider Activity at Cardlytics</h2>
<div class="lb-trans"><h2>Cardlytics 内部活动</h2>
</div><p>In other Cardlytics news, Director Scott A. Hill acquired 40,000 shares of the company's stock in a transaction that occurred on Monday, August 12th. The stock was bought at an average price of $3.58 per share, for a total transaction of $143,200.00. Following the acquisition, the director now directly owns 40,000 shares in the company, valued at $143,200. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at this hyperlink. In other news, CEO Amit Gupta sold 22,607 shares of the stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $3.85, for a total transaction of $87,036.95. Following the transaction, the chief executive officer now owns 178,519 shares of the company's stock, valued at approximately $687,298.15. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which can be accessed through this link. Also, Director Scott A. Hill purchased 40,000 shares of the company's stock in a transaction dated Monday, August 12th. The shares were purchased at an average cost of $3.58 per share, for a total transaction of $143,200.00. Following the transaction, the director now directly owns 40,000 shares in the company, valued at approximately $143,200. The disclosure for this purchase can be found here. Insiders sold a total of 43,573 shares of company stock worth $151,612 in the last quarter. 4.40% of the stock is owned by company insiders.</p>
<div class="lb-trans"><p>在其他 Cardlytics 的新闻中，董事 Scott A. Hill 在 8 月 12 日，星期一以每股平均价格 3.58 美元购买了 40,000 股公司的股票，总交易额为 143,200.00 美元。收购后，该董事现在直接持有 40,000 股公司股票，价值 143,200 美元。该交易已在向证券交易委员会提交的文件中披露，文件可通过此链接获取。在其他新闻中，首席执行官 Amit Gupta 在 10 月 24 日，星期四出售了 22,607 股股票，出售价格为每股 3.85 美元，总交易额为 87,036.95 美元。交易后，首席执行官现在持有 178,519 股公司股票，价值约 687,298.15 美元。这代表其持股比例下降了 0.00%。该交易已在向证券交易委员会提交的文件中披露，文件可通过此链接获取。此外，董事 Scott A. Hill 在 8 月 12 日，星期一以每股平均价格 3.58 美元购买了 40,000 股公司的股票，总交易额为 143,200.00 美元。交易后，该董事现在直接持有 40,000 股公司股票，价值约 143,200 美元。该购买的披露信息可在此处找到。内部人士在上个季度共出售了价值 151,612 美元的 43,573 股公司股票。公司内部人士持有 4.40% 的股份。</p>
</div><h2>Hedge Funds Weigh In On Cardlytics</h2>
<div class="lb-trans"><h2>对 Cardlytics 的对冲基金看法</h2>
</div><p>A number of hedge funds and other institutional investors have recently made changes to their positions in CDLX. Canton Hathaway LLC grew its position in shares of Cardlytics by 95.7% during the 2nd quarter. Canton Hathaway LLC now owns 4,500 shares of the company's stock worth $37,000 after buying an additional 2,200 shares in the last quarter. SG Americas Securities LLC bought a new position in shares of Cardlytics during the 3rd quarter worth $45,000. Creative Planning grew its position in shares of Cardlytics by 35.4% during the 3rd quarter. Creative Planning now owns 29,537 shares of the company's stock worth $95,000 after buying an additional 7,721 shares in the last quarter. XTX Topco Ltd bought a new position in shares of Cardlytics during the 2nd quarter worth $107,000. Finally, Quest Partners LLC boosted its position in Cardlytics by 160.4% during the second quarter. Quest Partners LLC now owns 17,956 shares of the company's stock valued at $147,000 after purchasing an additional 11,061 shares in the last quarter. Institutional investors own 68.10% of the company's stock.</p>
<div class="lb-trans"><p>一些对冲基金和其他机构投资者最近对 CDLX 的持仓进行了调整。Canton Hathaway LLC 在第二季度将其在 Cardlytics 的持仓增加了 95.7%。Canton Hathaway LLC 现在持有 4,500 股公司股票，价值 37,000 美元，此前在上个季度又购买了 2,200 股。SG Americas Securities LLC 在第三季度购买了 Cardlytics 的新头寸，价值 45,000 美元。Creative Planning 在第三季度将其在 Cardlytics 的持仓增加了 35.4%。Creative Planning 现在持有 29,537 股公司股票，价值 95,000 美元，此前在上个季度又购买了 7,721 股。XTX Topco Ltd 在第二季度购买了 Cardlytics 的新头寸，价值 107,000 美元。最后，Quest Partners LLC 在第二季度将其在 Cardlytics 的持仓增加了 160.4%。Quest Partners LLC 现在持有 17,956 股公司股票，价值 147,000 美元，此前在上个季度又购买了 11,061 股。机构投资者持有公司 68.10% 的股份。</p>
</div><h2>Cardlytics Company Profile</h2>
<div class="lb-trans"><h2>Cardlytics 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.</p>
<div class="lb-trans"><p>Cardlytics, Inc 在美国和英国运营一个广告平台。它提供 Cardlytics 平台，这是一个专有的本地银行广告渠道，使营销人员能够通过其金融机构合作伙伴的网络通过在线、移动应用程序、电子邮件和各种实时通知等数字渠道接触客户；以及 Bridg 平台，这是一个客户数据平台，利用销售点数据，使营销人员能够进行分析和针对性忠诚营销，并衡量其营销的影响。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Cardlytics</li>
<li>Pros And Cons Of Monthly Dividend Stocks</li>
<li>Gilead’s Stock Surge: What’s Fueling the Momentum?</li>
<li>Dividend Payout Ratio Calculator</li>
<li>Breakout Alert: Qualcomm Just Hit The Rally Button</li>
<li>ESG Stocks, What Investors Should Know</li>
<li>Mercado Libre Shares Go on Sale: Is Now the Time to Buy?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是 Cardlytics</li>
<li>每月分红股票的利弊</li>
<li>吉利德股票飙升：是什么推动了这一势头？</li>
<li>分红支付比率计算器</li>
<li>突破警报：高通刚刚按下了反弹按钮</li>
<li>ESG 股票，投资者应该知道什么</li>
<li>Mercado Libre 股票降价：现在是购买的时机吗？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0RMWA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=CDLX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><p>→ Ex WH Advisor Who Predicted Biden Leaving Race Makes Startling New Prediction (From Paradigm Press)(Ad)</p>
<div class="lb-trans"><p>→ 前白宫顾问预测拜登退出竞选，做出惊人新预测（来自 Paradigm Press）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDM5Mg" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=10392&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Cardlytics right now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Cardlytics 吗？</h2>
</div><p>Before you consider Cardlytics, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Cardlytics 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardlytics wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Cardlytics 并不在名单上。</p>
</div><p>While Cardlytics currently has a &#34;Reduce&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Cardlytics 目前在分析师中被评为 “减持”，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Cardlytics (NASDAQ:CDLX) 的股票评级被 Craig Hallum 上调